TSX open
Loading markets…

Advertisement

Stocks

GE HealthCare to announce third quarter 2026 results on October 28, 2026

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:GEHC.US

Follow GEHC

Photos provided by Pexels

GE HealthCare is set to release its third quarter earnings later this month.

GE HealthCare Technologies Inc. announced it will report its third quarter 2026 results on October 28, 2026. The company's stock closed at US$64.20, down 1.48% for the day and 2.54% over the past week. Year-to-date, the stock has dropped by 21.68%, highlighting ongoing challenges in the market.

Advertisement

GE HealthCare Technologies Inc.

GEHC.US

Full stock page →

GEHC.US

GE HealthCare Technologies Inc.

Source:WealthAwesomeWealthAwesome
↓ $3.60 (-5.05%)
120 day period
$59.45$67.14$74.82Apr 22Jul 20Oct 12

Market cap

$30.81B

P/E

15.6x

Div. yield

0.21%

Div. / share

$0.14

52W high

$89.64

52W low

$58.72

1W change

+3.04%

Beta

0.85

Analyst Price Targets

Based on 21 analysts covering GEHC · as of Oct 12, 2026

📈

Wall Street analysts forecast GEHC stock price to rise 22.4% over the next 12 months.

Consensus

Buy

4.24 / 5.00

Avg. Target

C$82.90

+22.4% Upside

Current Price

C$67.74

Last close

Analyst Breakdown (21 analysts)

Strong Buy 10
Buy 6
Hold 5
Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on GEHC's historical volatility

HistoricalForecast68%95%
C$55.53C$64.92C$74.30C$83.69C$93.08C$102.47TodayJun 4Aug 10Oct 12Nov 24Jan 7Feb 19

30-Day Vol

23.1%

Annualized

90-Day Vol

34.9%

Annualized

Trend (90d)

+30.2%

Annualized drift

90d Mean

C$75.47

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$70.22C$64.84 – C$76.05
60 trading daysC$72.80C$65.03 – C$81.49
90 trading daysC$75.47C$65.73 – C$86.65

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: Investors should keep an eye on the upcoming earnings announcement for insights into the company's financial performance.

Latest close at US$64.20, down 1.48% on the day

The recent trading volume was 166,369 shares, lower than the 20-day average volume of 3,725,474 shares, indicating reduced trading activity.

Bull case

Analysts have set an average target price of US$82.79 for GE HealthCare, suggesting a potential upside of 29.0% from the current trading price. This indicates that if the company can address its challenges effectively, there may be significant growth ahead.

Bear case

The stock has seen a notable decline of 21.68% year-to-date, raising concerns about its market position and future growth. Investors should be cautious, as this downward trend could continue if the company does not improve its performance.

Earnings Announcement Scheduled for October 28, 2026

Advertisement

GE HealthCare Technologies Inc. has confirmed it will release its third quarter earnings report on October 28, 2026. This announcement is crucial as it may offer insights into the company’s operational performance and financial health. The stock closed at US$64.20, significantly below its 50-day moving average of US$68.82 and its 200-day moving average of US$71.19, indicating potential challenges in maintaining upward momentum in the stock price.

Recent Stock Performance and Trading Volume

As of the latest trading session, GE HealthCare's stock closed at US$64.20, reflecting a decrease of 1.48% for the day. The stock has experienced a substantial decline of 21.68% year-to-date, with a 1-month decrease of 5.94%. Recent trading volume was 166,369 shares, which is only 0.95 times the 20-day average volume of 3,725,474 shares, suggesting reduced investor interest and trading activity over the recent period.

What to Watch Ahead of the Earnings Report

Investors will be closely watching GE HealthCare’s upcoming earnings report for key metrics such as revenue growth, profit margins, and updates on strategic initiatives, including the recent acquisition of Sofie Biosciences for $945 million. The company has a P/E ratio of 14.89 and a profit margin of 9.3%, which may provide context for evaluating the earnings results. With an average analyst target price of US$82.79, there could be significant upside if the company meets or exceeds expectations.

Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: October 7, 2026
Last Updated: October 7, 2026

Core portfolio

Awesome Portfolio™

14.8% a year since 2017, against 9.7% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+14.8%

Awesome Portfolio™

+9.7%

S&P/TSX

+5.0 pp better a year

Total return

+254%

Awesome Portfolio™

+134%

S&P/TSX

+119 pp better than the TSX

2017-07-31 to 2026-09-29, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-29
-11.7%42.5%96.7%150.9%205.1%259.3%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement